Bruton Tyrosine Kinase Inhibitors in Patients with Multiple Sclerosis

home / peer-exchange / bruton-tyrosine-kinase-inhibitors-in-patients-with-multiple-sclerosis

Ryan Haumschild, PharmD, MS, MBA leads a panel of medical experts in a discussion surrounding the potential role of BTK inhibitors in the treatment of multiple sclerosis.

Episodes

CH LogoCenter for Biosimilars Logo